<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0410462</journal-id><journal-id journal-id-type="pubmed-jr-id">6011</journal-id><journal-id journal-id-type="nlm-ta">Nature</journal-id><journal-id journal-id-type="iso-abbrev">Nature</journal-id><journal-title-group><journal-title>Nature</journal-title></journal-title-group><issn pub-type="ppub">0028-0836</issn><issn pub-type="epub">1476-4687</issn></journal-meta><article-meta><article-id pub-id-type="pmid">29342138</article-id><article-id pub-id-type="pmc">PMC6007875</article-id><article-id pub-id-type="doi">10.1038/nature25451</article-id><article-id pub-id-type="manuscript">NIHMS927628</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>&#x003b1;Klotho is a Non-Enzymatic Molecular Scaffold for FGF23 Hormone Signaling</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Gaozhi</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="author-notes" rid="FN2">#</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="author-notes" rid="FN2">#</xref></contrib><contrib contrib-type="author"><name><surname>Goetz</surname><given-names>Regina</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="author-notes" rid="FN3">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Lili</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jayaraman</surname><given-names>Seetharaman</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Ming-Chang</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Moe</surname><given-names>Orson W.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Guang</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiaokun</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Mohammadi</surname><given-names>Moosa</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China</aff><aff id="A2">
<label>2</label>Department of Biochemistry &#x00026; Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA</aff><aff id="A3">
<label>3</label>New York Structural Biology Center, New York, NY 10027, USA</aff><aff id="A4">
<label>4</label>Departments of Internal Medicine and Physiology, and Charles and Jane Pak Center of Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA</aff><author-notes><corresp id="FN1"><label>*</label>To whom correspondence should be addressed: <email>moosa.mohammadi@nyumc.org</email> or <email>xiaokunli@wzmu.edu.cn</email></corresp><fn id="FN2" fn-type="equal"><label>#</label><p id="P1">These authors contributed equally</p></fn><fn id="FN3"><label>&#x02020;</label><p id="P2">Presently self-employed</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>13</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>17</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="ppub"><day>25</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>7</month><year>2018</year></pub-date><volume>553</volume><issue>7689</issue><fpage>461</fpage><lpage>466</lpage><!--elocation-id from pubmed: 10.1038/nature25451--><permissions><license><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p></license></permissions><abstract><title>Summary</title><p id="P3">The aging suppressor &#x003b1;Klotho binds to the fibroblast growth factor receptor (FGFR). This commits FGFR to respond to FGF23, a key hormone in the regulation of mineral ion/vitamin D homeostasis. The role and mechanism of this co-receptor are unknown. Here we present the atomic structure of a 1:1:1 ternary complex consisting of the shed extracellular domain of &#x003b1;Klotho, the FGFR1c ligand-binding domain, and FGF23. In this complex, &#x003b1;Klotho simultaneously tethers FGFR1c by its D3 domain and FGF23 by its C-terminal tail, thus implementing FGF23-FGFR1c proximity and conferring stability. The endocrine character of FGF23 notwithstanding, dimerization of the stabilized ternary complexes and receptor activation remain dependent on the binding of heparan sulfate, a mandatory cofactor of paracrine FGF signaling. The structure of &#x003b1;Klotho is incompatible with its purported glycosidase activity. Thus, shed &#x003b1;Klotho functions as an on-demand non-enzymatic scaffold protein that promotes FGF23 signaling.</p></abstract></article-meta></front><body><p id="P4">Endocrine fibroblast growth factor 23 (FGF23) regulates phosphate and vitamin D homeostasis by reducing cell surface expression of sodium phosphate co-transporters and by repressing transcription of rate-limiting enzymes for vitamin D biosynthesis<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> in the kidney. FGF23 exerts its metabolic functions by binding and activating FGF receptor tyrosine kinases (FGFRs)<sup><xref rid="R3" ref-type="bibr">3</xref></sup> in an &#x003b1;Klotho co-receptor dependent fashion. The extracellular domain of a prototypical FGFR consists of three immunoglobulin-like domains: D1, D2, and D3. The membrane proximal portion comprising D2, D3, and the D2-D3 linker (FGFR<sup>ecto</sup>) is both necessary and sufficient for FGF ligand binding<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup>. Tissue-specific alternative splicing in the D3 domain of FGFR1-3 generates &#x0201c;b&#x0201d; and &#x0201c;c&#x0201d; isoforms, each with distinct ligand-binding specificity<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup>. &#x003b1;Klotho, fortuitously discovered as an aging suppressor gene<sup><xref rid="R7" ref-type="bibr">7</xref></sup>, is a single-pass transmembrane protein with an extracellular domain composed of two tandem domains (KL1 and KL2), each with significant homology to family 1 glycosidases<sup><xref rid="R8" ref-type="bibr">8</xref></sup> (<xref ref-type="fig" rid="F6">Extended Data Fig. 1a</xref>). Membrane-bound &#x003b1;Klotho (&#x003b1;Klotho&#x02122;) associates with cognate FGFRs of FGF23, namely the &#x0201c;c&#x0201d; splice isoforms of FGFR1 and FGFR3 (FGFR1c and FGFR3c) and FGFR4<sup><xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R12" ref-type="bibr">12</xref></sup>. This enables them to bind and respond to FGF23<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup>. &#x003b1;Klotho&#x02122; is predominantly expressed in the kidney distal tubules, the parathyroid gland, and the brain choroid plexus<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup>, and this is considered to determine target tissue specificity of FGF23<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup>. Cleavage of &#x003b1;Klotho&#x02122; by ADAM proteases<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup> in kidney distal tubules sheds the &#x003b1;Klotho ectodomain (&#x003b1;Klotho<sup>ecto</sup>; <xref ref-type="fig" rid="F6">Extended Data Fig. 1a</xref>) into body fluids, e.g. serum, urine, and cerebrospinal fluid<sup><xref rid="R16" ref-type="bibr">16</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref></sup>. &#x003b1;Klotho<sup>ecto</sup> is thought to lack co-receptor activity and act as a circulating anti-aging hormone independent of FGF23<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup>. A plethora of activities has been attributed to shed &#x003b1;Klotho<sup>ecto</sup>, the bulk of which require a purported intrinsic glycosidase activity<sup><xref rid="R22" ref-type="bibr">22</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref></sup>.</p><p id="P5">Here we show that circulating &#x003b1;Klotho<sup>ecto</sup> is an on-demand <italic>bona fide</italic> co-receptor for FGF23, and determine its crystal structure in complex with FGFR1c<sup>ecto</sup> and FGF23. The structure reveals that &#x003b1;Klotho serves as a non-enzymatic scaffold that simultaneously tethers FGFR1c and FGF23 to implement FGF23-FGFR1c proximity and hence stability. Surprisingly, heparan sulfate (HS), a mandatory cofactor for paracrine FGFs, is still required as an ancillary cofactor to promote the formation of a symmetric 2:2:2:2 FGF23-FGFR1c-&#x003b1;Klotho-HS quaternary signaling complex.</p><sec id="S1"><title>Soluble &#x003b1;Klotho<sup>ecto</sup> acts as a co-receptor for FGF23</title><p id="P6">To determine whether soluble &#x003b1;Klotho<sup>ecto</sup> can support FGF23 signaling, &#x003b1;Klotho-deficient HEK293 cells &#x02013; which naturally express FGFRs &#x02013; were incubated with a concentration of &#x003b1;Klotho<sup>ecto</sup> sufficient to drive all available cell surface cognate FGFRs into binary complexed form. Following brief rinses with PBS, the cells were stimulated with increasing concentrations of FGF23. In parallel, a HEK293 cell line overexpressing membrane-bound &#x003b1;Klotho (HEK293-&#x003b1;Klotho&#x02122;) was treated with increasing concentrations of FGF23. The dose-response for FGF23-induced ERK phosphorylation in &#x003b1;Klotho<sup>ecto</sup>-pretreated untransfected HEK293 cells was similar to that observed in HEK293-&#x003b1;Klotho&#x02122; cells (<xref ref-type="fig" rid="F6">Extended Data Fig. 1b</xref>, upper panel), suggesting that &#x003b1;Klotho<sup>ecto</sup> can serve as a co-receptor for FGF23. Pre-treatment of HEK293-&#x003b1;Klotho&#x02122; cells with &#x003b1;Klotho<sup>ecto</sup> did not result in any further increase in FGF23 signaling, implying that all cell surface FGFRs in this cell line were in binary FGFR-&#x003b1;Klotho&#x02122; form (<xref ref-type="fig" rid="F6">Extended Data Fig. 1b</xref>, lower panel). We conclude that soluble and transmembrane forms of &#x003b1;Klotho possess a similar capacity to support FGF23 signaling. Consistent with these results, injection of wild-type mice with &#x003b1;Klotho<sup>ecto</sup> protein led to an increase in renal phosphate excretion and a decrease in serum phosphate (<xref ref-type="fig" rid="F6">Extended Data Fig. 1c</xref>). Notably, it also led to a 1.5-fold increase in Egr1 transcripts in the kidney (<xref ref-type="fig" rid="F6">Extended Data Fig. 1d</xref>), demonstrating that &#x003b1;Klotho<sup>ecto</sup> can serve as a <italic>bona fide</italic> co-receptor to support FGF23 signaling in renal proximal tubules. In light of these data, we propose that the pleiotropic anti-aging effects of &#x003b1;Klotho are all dependent on FGF23.</p></sec><sec id="S2"><title>Structural basis for &#x003b1;Klotho co-receptor function</title><p id="P7">We solved the crystal structure of a human 1:1:1 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> ternary complex at 3.0 &#x000c5; resolution (<xref ref-type="table" rid="T1">Extended Data Table 1</xref>). In this complex, &#x003b1;Klotho<sup>ecto</sup> serves as a massive scaffold, tethering both FGFR1c and FGF23 to itself. In doing so, &#x003b1;Klotho<sup>ecto</sup> enforces FGF23-FGFR1c proximity and thus augments FGF23-FGFR1c binding affinity (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The overall geometry of the ternary complex is compatible with its formation on the cell surface (<xref ref-type="fig" rid="F7">Extended Data Fig. 2a</xref>).</p><p id="P8">The binary FGF23-FGFR1c<sup>ecto</sup> complex adopts a canonical FGF-FGFR complex topology in which FGF23 is bound between the receptor&#x02019;s D2 and D3 domains, engaging both these domains and a short interdomain linker (<xref ref-type="fig" rid="F8">Extended Data Fig. 3a</xref>). However, compared to paracrine FGFs, FGF23 makes fewer/weaker contacts with the D3 domain and D2-D3 linker, explaining the inherently low affinity of FGF23 for FGFR1c (<xref ref-type="fig" rid="F8">Extended Data Fig. 3b, c</xref>). Notably, analysis of the binding interface between FGF23 and FGFR1c D3 in the crystal structure reveals specific contacts between FGF23 and a serine residue uniquely present in the &#x0201c;c&#x0201d; splice isoforms of FGFR1-3 and FGFR4 (<xref ref-type="fig" rid="F9">Extended Data Fig. 4a</xref>). Indeed, replacing this &#x0201c;c&#x0201d;-isoform specific serine residue with a &#x0201c;b&#x0201d;-isoform specific tyrosine impaired FGF23 signaling (<xref ref-type="fig" rid="F9">Extended Data Fig. 4b, c</xref>). We conclude that the FGFR binding specificity inherent to FGF23 operates alongside that of &#x003b1;Klotho (<xref ref-type="fig" rid="F9">Extended Data Fig. 4d, e</xref>) to restrict FGF23 signaling to the &#x0201c;c&#x0201d; splice isoforms and FGFR4<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup>.</p><p id="P9">In the ternary complex, &#x003b1;Klotho<sup>ecto</sup> exists in an extended conformation. Consistent with their sequence homology to the glycoside hydrolase A (GH-A) clan<sup><xref rid="R8" ref-type="bibr">8</xref></sup>, &#x003b1;Klotho KL1 (Glu-34 to Phe-506) and KL2 (Leu-515 to Ser-950) domains each assume a (&#x003b2;&#x003b1;)<sub>8</sub> TIM barrel fold consisting of an inner eight-stranded parallel &#x003b2;-barrel and eight surrounding &#x003b1;-helices (<xref ref-type="fig" rid="F2">Fig. 2a</xref> and <xref ref-type="fig" rid="F10">Extended Data Fig. 5a</xref>). The two KL domains are connected by a short, proline-rich and hence stiff linker (Pro-507 to Pro-514) (<xref ref-type="fig" rid="F1">Fig. 1a, b</xref>). KL1 sits atop KL2, engaging it via a few interdomain contacts involving the N-terminus preceding the &#x003b2;1 strand, the &#x003b1;7 helix of KL1, and the &#x003b2;5&#x003b1;5, &#x003b2;6&#x003b1;6 loops and the &#x003b1;7 helix of KL2 (<xref ref-type="fig" rid="F7">Extended Data Fig. 2b</xref>). Intriguingly, one of the interdomain contacts is mediated by a Zn<sup>2+</sup> ion (<xref ref-type="fig" rid="F3">Fig. 3c</xref> and <xref ref-type="fig" rid="F7">Extended Data Fig. 2b, c</xref>). These contacts stabilize the observed elongated conformation of &#x003b1;Klotho<sup>ecto</sup>, creating a deep cleft between the two KL domains. This merges with a wide-open central &#x003b2;-barrel cavity in KL2, and forms a large binding pocket that tethers the distal C-terminal tail of FGF23 past the <sup>176</sup>Arg-His-Thr-Arg<sup>179</sup> proteolytic cleavage site (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). Meanwhile, the long &#x003b2;1&#x003b1;1 loop of KL2 (<xref ref-type="fig" rid="F2">Fig. 2a</xref>) protrudes as much as 35 &#x000c5; away from the KL2 core to latch onto the FGFR1c D3 domain, thus anchoring the receptor to &#x003b1;Klotho (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). Accordingly, we have named this KL2 loop the &#x0201c;Receptor Binding Arm&#x0201d; (RBA; residues 530-578; <xref ref-type="fig" rid="F10">Extended Data Fig. 5a</xref>).</p><p id="P10">We superimposed the TIM barrels of KL1 and KL2 onto that of <underline>Kl</underline>otho <underline>R</underline>elated <underline>P</underline>rotein (KLrP; also known as GBA3), the cytosolic member of the Klotho family with proven glycosylceramidase activity<sup><xref rid="R26" ref-type="bibr">26</xref></sup>. This comparison revealed major conformational differences in the loops surrounding the entrance to the catalytic pocket in KL1 and KL2 (<xref ref-type="fig" rid="F2">Fig. 2b</xref> and <xref ref-type="fig" rid="F10">Extended Data Fig. 5b&#x02013;d</xref>). Moreover, both KL domains lack one of the key catalytic glutamates deep within the putative catalytic pocket. These substantial differences are incompatible with an intrinsic glycosidase activity for &#x003b1;Klotho<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup>. Indeed, &#x003b1;Klotho<sup>ecto</sup> failed to hydrolyze substrates for both sialidase and &#x003b2;-glucuronidase <italic>in vitro</italic> (<xref ref-type="fig" rid="F2">Fig. 2c</xref>). Together, our data define &#x003b1;Klotho as the only known example of a TIM barrel protein that serves purely as a non-enzymatic molecular scaffold.</p></sec><sec id="S3"><title>Binding interface between &#x003b1;Klotho and FGFR1c</title><p id="P11">The interface between &#x003b1;Klotho RBA and FGFR1c D3 (<xref ref-type="fig" rid="F3">Fig. 3a</xref>) buries over 2,200 &#x000c5;<sup>2</sup> of solvent-exposed surface area, which is consistent with the high affinity of &#x003b1;Klotho binding to FGFR1c (K<sub>D</sub> = 72 nM)<sup><xref rid="R10" ref-type="bibr">10</xref></sup>. At the distal tip of the RBA, residues <sup>547</sup>Tyr-Leu-Trp<sup>549</sup> and <sup>556</sup>Ile-Leu-Arg<sup>558</sup> form a short &#x003b2;-strand pair (RBA-&#x003b2;1:RBA-&#x003b2;2) as their hydrophobic side chains are immersed in a wide hydrophobic groove between the four-stranded &#x003b2;C&#x02019;-&#x003b2;C-&#x003b2;F-&#x003b2;G sheet and the &#x003b2;C-&#x003b2;C&#x02019; loop of FGFR1c D3 (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, upper panel). The RBA-&#x003b2;1:RBA-&#x003b2;2 strand pair forms an extended &#x003b2; sheet with the &#x003b2;C&#x02019;-&#x003b2;C-&#x003b2;F-&#x003b2;G sheet of D3 as the backbone atoms of RBA-&#x003b2;1 and D3 &#x003b2;C&#x02019; make three hydrogen bonds which further augment the interface (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, lower panel). Residues at the proximal end of the RBA engage a second smaller binding pocket at the bottom edge of D3 next to the hydrophobic groove (<xref ref-type="fig" rid="F11">Extended Data Fig. 6a, b</xref>). Both &#x003b1;Klotho binding pockets in the receptor D3 domain differ between &#x0201c;b&#x0201d; and &#x0201c;c&#x0201d; splice isoforms. Leu-342, for example, is strictly conserved in the &#x0201c;c&#x0201d; splice isoforms of FGFR1-3 and FGFR4. This explains the previously described binding selectivity of &#x003b1;Klotho for this subset of FGFRs (<xref ref-type="fig" rid="F9">Extended Data Fig. 4a</xref>)<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup>.</p><p id="P12">Consistent with the crystal structure, soluble &#x003b1;Klotho lacking the RBA (&#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup>) failed to form a binary complex with FGFR1c<sup>ecto</sup> in solution (<xref ref-type="fig" rid="F4">Fig. 4a</xref>) and hence could not support FGF23 signaling (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). Likewise, membrane-bound &#x003b1;Klotho lacking the RBA (&#x003b1;Klotho<sup>TM/&#x00394;RBA</sup>) was also disabled in acting as a FGF23 co-receptor (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). Importantly, &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> did not exhibit any phosphaturic activity <italic>in vivo</italic> (<xref ref-type="fig" rid="F12">Extended Data Fig. 7a</xref>). On the contrary, the &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> mutant antagonized the activity of native &#x003b1;Klotho by sequestering FGF23 into functionally inactive binary complexes, i.e. by acting as an FGF23 ligand trap (<xref ref-type="fig" rid="F12">Extended Data Fig. 7</xref>). These data refute the concept that &#x003b1;Klotho<sup>ecto</sup> functions as an FGF23-independent phosphaturic enzyme<sup><xref rid="R24" ref-type="bibr">24</xref></sup>. Our conclusion is supported by a gene knockout study which compared the phenotypes of <italic>Fgf23</italic><sup>&#x02212;/&#x02212;</sup>, <italic>Klotho</italic><sup>&#x02212;/&#x02212;</sup>, and <italic>Fgf23</italic><sup>&#x02212;/&#x02212;</sup>/<italic>Klotho</italic><sup>&#x02212;/&#x02212;</sup> mice<sup><xref rid="R28" ref-type="bibr">28</xref></sup>.</p></sec><sec id="S4"><title>Binding interface between &#x003b1;Klotho and FGF23</title><p id="P13">Regions from both KL domains act together to recruit FGF23 (<xref ref-type="fig" rid="F1">Fig. 1b</xref>), thus explaining why only an intact &#x003b1;Klotho ectodomain is capable of supporting FGF23 signaling<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup>. The interactions between FGF23 and &#x003b1;Klotho result in the burial of a large amount of solvent-exposed surface area (2,732 &#x000c5;<sup>2</sup>), of which nearly two-thirds (1961 &#x000c5;<sup>2</sup>) are buried between the FGF23 C-terminal tail and &#x003b1;Klotho, with the remaining one-third buried between the FGF23 core and &#x003b1;Klotho (<xref ref-type="fig" rid="F3">Fig. 3a</xref>). At the interface between &#x003b1;Klotho and FGF23 C-terminal tail, FGF23 residues <sup>188</sup>Asp-Pro-Leu-Asn-Val-Leu<sup>193</sup> adopt an unusual cage-like conformation (<xref ref-type="fig" rid="F3">Fig. 3a, c</xref>) which is tethered by residues from both KL domains via hydrogen bonds and hydrophobic contacts deep inside the KL1-KL2 cleft (<xref ref-type="fig" rid="F3">Fig. 3c</xref>). Further downstream, the side chains of Lys-194, Arg-196, and Arg-198 of the FGF23 C-terminal tail dip into the central barrel cavity of KL2, making hydrogen bonds with multiple &#x003b1;Klotho residues (<xref ref-type="fig" rid="F3">Fig. 3c</xref>). At the interface between the FGF23 &#x003b2;-trefoil core and &#x003b1;Klotho, residues from the &#x003b2;5&#x02013;&#x003b2;6 turn and the &#x003b1;C helix of FGF23 make hydrogen bonds and hydrophobic contacts with residues in the short &#x003b2;7-&#x003b1;7 and &#x003b2;8-&#x003b1;8 loops at the upper rim of the KL2 cavity (<xref ref-type="fig" rid="F11">Extended Data Fig. 6a, c</xref>).</p><p id="P14">To test the biological relevance of the observed contacts between &#x003b1;Klotho and FGF23 C-terminal tail, we introduced multiple mutations into &#x003b1;Klotho&#x02122; and FGF23 in order to disrupt &#x003b1;Klotho-FGF23 binding (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). Consistent with our structure-based predictions, all &#x003b1;Klotho&#x02122; mutants showed an impaired ability to support FGF23 signaling (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). The FGF23 mutants also exhibited a reduced ability to signal, regardless of whether soluble or membrane-bound &#x003b1;Klotho served as co-receptor (<xref ref-type="fig" rid="F4">Fig. 4d</xref>). Remarkably, the FGF23<sup>D188A</sup> mutant (which eliminates the intramolecular hydrogen bonds that support cage conformation) was totally inactive, underscoring the importance of the cage-like conformation in the tethering of FGF23 to &#x003b1;Klotho. Notably, tethering of this cage-like structure requires a precise alignment of residues from both KL domains deep within the KL1-KL2 cleft (<xref ref-type="fig" rid="F3">Fig. 3c</xref>), implying that their correct apposition is critically important for &#x003b1;Klotho co-receptor activity. These structural observations suggest that the bound Zn<sup>2+</sup> ion serves as a prosthetic group in &#x003b1;Klotho by minimizing interdomain flexibility and hence promoting co-receptor activity. Consistent with such a role, mutants of membrane-anchored &#x003b1;Klotho&#x02122; carrying alanine in place of two, three, or all four Zn<sup>2+</sup> coordinating amino acids (<xref ref-type="fig" rid="F3">Fig. 3c</xref>) showed a reduced ability to support FGF23 signaling (<xref ref-type="fig" rid="F4">Fig. 4e</xref>). Together with our data on the impact of RBA deletion, these results corroborate the biological relevance of the crystallographically-deduced mode by which &#x003b1;Klotho implements FGF23-FGFR1c proximity and thus confers high binding affinity.</p></sec><sec id="S5"><title>FGF23 signaling is &#x003b1;Klotho and HS-dependent</title><p id="P15">Both FGF23 and FGFR1c have a measurable (albeit weak) binding affinity for HS. Because HS is ubiquitously expressed, we wondered whether it participates in the apparent &#x003b1;Klotho<sup>ecto</sup>-mediated FGF23-FGFR dimerization in our cell-based and <italic>in vivo</italic> experiments. We therefore analyzed the molecular mass of the ternary complex in the absence and presence of increasing molar equivalents of homogenously sulfated heparin hexasaccharide (HS6). Consistent with our previous observations, in the absence of HS6, the ternary complex migrated as a monomeric species<sup><xref rid="R10" ref-type="bibr">10</xref></sup> with an apparent molecular mass of 150 kDa, in good agreement with the theoretical value for a 1:1:1 complex (160 kDa) (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). With increasing molar ratios of HS6 to ternary complex, the peak for monomeric ternary complex diminished, while a new peak with a molecular mass of 300 kDa (corresponding to a 2:2:2 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> dimer) appeared and increased in prominence. Excess HS6 beyond a 1:1 molar ratio of HS6 to ternary complex did not lead to any further increase in the amount of dimer complex formed, as judged by the integrated area of the dimer complex peak (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). We conclude that HS is required for the dimerization of 1:1:1 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complexes, and that at least a 1:1 molar ratio of HS6 to ternary complex is required for complete dimerization of the complex in solution (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). To further confirm the HS-dependency of dimerization, we introduced mutations into the HS-binding sites of FGFR1c (K160Q/K163Q, FGFR1c<sup>&#x00394;HBS</sup>, and K207Q/R209Q, FGFR1c<sup>&#x00394;HBS&#x02019;</sup>) and FGF23 (R140A/R143A; FGF23<sup>&#x00394;HBS</sup>). Neither mutating the HS-binding site in FGFR1c nor mutating that site in FGF23 impacted the formation of a monomeric 1:1:1 FGF23-FGFR1c-&#x003b1;Klotho complex in solution, demonstrating that &#x003b1;Klotho-mediated stabilization of the FGF23-FGFR complex is HS-independent. However, ternary complexes containing any of these three mutants failed to dimerize in the presence of HS6 (<xref ref-type="fig" rid="F5">Fig. 5b</xref>).</p><p id="P16">Reconstitution experiments in the context of BaF3 cells (an FGFR, &#x003b1;Klotho, and HS triple deficient cell line<sup><xref rid="R30" ref-type="bibr">30</xref></sup>) showed that both soluble &#x003b1;Klotho<sup>ecto</sup> and membrane-bound &#x003b1;Klotho&#x02122; required HS to support FGF23-mediated FGFR1c activation in a more physiological context (<xref ref-type="fig" rid="F5">Fig. 5c</xref>). We also examined the impact of the HS-binding site mutations in FGFR1c and FGF23 on FGFR1c activation by FGF23 in BaF3 cells (<xref ref-type="fig" rid="F5">Fig. 5d</xref>). In agreement with our solution binding data, activation by FGF23 of HS-binding site mutants of FGFR1c in BaF3 cells was markedly impaired, regardless of whether soluble or membrane-bound &#x003b1;Klotho served as the co-receptor (<xref ref-type="fig" rid="F5">Fig. 5d</xref>). Similarly, the HS-binding site mutant of FGF23 showed a significantly reduced ability to activate FGFR1c (<xref ref-type="fig" rid="F5">Fig. 5e</xref>). These <italic>in vitro</italic> and cell-based analyses unequivocally demonstrate that whereas HS fulfills a dual role in paracrine FGF signaling &#x02013; enhancing 1:1 FGF-FGFR binding and promoting 2:2 FGF-FGFR dimerization &#x02013; it shares this task with &#x003b1;Klotho in FGF23 signaling. Thus, &#x003b1;Klotho primarily acts to promote 1:1 FGF23-FGFR1c binding, whereas HS induces dimerization of the resulting FGF23-FGFR1c-&#x003b1;Klotho complexes.</p><p id="P17">Based on the crystallographically-deduced 2:2:2 (PDB ID: 1FQ9)<sup><xref rid="R4" ref-type="bibr">4</xref></sup> and 2:2:1 (PDB ID: 1E0O)<sup><xref rid="R31" ref-type="bibr">31</xref></sup> paracrine FGF-FGFR-HS dimerization models, two distinct HS-induced 2:2:2 endocrine FGF23-FGFR1c-&#x003b1;Klotho quaternary dimers can be envisioned that differ dramatically in the composition of the dimer interface (<xref ref-type="fig" rid="F13">Extended Data Fig. 8</xref>). Specifically, in the 2:2:2:1 model, there would be no protein-protein contacts between the two 1:1:1 FGF-FGFR-&#x003b1;Klotho protomers (<xref ref-type="fig" rid="F13">Extended Data Fig. 8a</xref>). By contrast, in the 2:2:2:2 model, FGF23 and FGFR from one 1:1:1 FGF-FGFR-&#x003b1;Klotho protomer would interact with the D2 domain of FGFR in the adjacent 1:1:1 FGF-FGFR-&#x003b1;Klotho protomer across a two-fold dimer interface (<xref ref-type="fig" rid="F13">Extended Data Fig. 8b</xref>). Based on the fundamental differences in the composition of the dimer interface between these two models, we introduced mutations into the <underline>s</underline>econdary-<underline>r</underline>eceptor-<underline>b</underline>inding <underline>s</underline>ite (SRBS) in FGF23 (M149A/N150A/P151A; FGF23<sup>&#x00394;SRBS</sup>) and into the corresponding <underline>s</underline>econdary-<underline>l</underline>igand-<underline>b</underline>inding <underline>s</underline>ite (SLBS) in FGFR1c D2 (I203E, FGFR1c<sup>&#x00394;SLBS</sup>, and V221D, FGFR1c<sup>&#x00394;SLBS&#x02019;</sup>), both of which are unique to the 2:2:2:2 quaternary dimer model. The direct <underline>r</underline>eceptor-<underline>r</underline>eceptor <underline>b</underline>inding <underline>s</underline>ite in FGFR1c D2 (A171D; FGFR1c<sup>&#x00394;RRBS</sup>), another binding site unique to the 2:2:2:2 model, was also mutated (<xref ref-type="fig" rid="F13">Extended Data Fig. 8b</xref>). While all these FGF23 and FGFR1c mutants were able to form ternary complexes with &#x003b1;Klotho<sup>ecto</sup>, the ternary complexes containing any of the mutated proteins were impaired in their ability to dimerize in the presence of HS6 in solution (<xref ref-type="fig" rid="F5">Fig. 5f</xref>). Moreover, FGF23<sup>&#x00394;SRBS</sup> mutant showed a markedly diminished ability to activate FGFR1c in BaF3 cells (<xref ref-type="fig" rid="F5">Fig. 5e</xref>). The loss-of-function effects of these mutations are consistent with a 2:2:2:2 quaternary dimer model (<xref ref-type="fig" rid="F13">Extended Data Fig. 8b</xref>). Hence, we envision that HS engages the HS-binding sites of FGFR1c and FGF23 in two stabilized 1:1:1 FGF23-FGFR1c-&#x003b1;Klotho ternary complexes to promote the formation of a two-fold symmetric 2:2:2:2 FGF23-FGFR1c-&#x003b1;Klotho-HS dimer (<xref ref-type="fig" rid="F5">Fig. 5g</xref>). In doing so, HS enhances reciprocal interactions of FGFR1c D2 and FGF23 from one ternary complex with FGFR1c D2 in the other ternary complex, thereby buttressing the dimer (<xref ref-type="fig" rid="F13">Extended Data Fig. 8b</xref>). This replicates the role that HS plays in paracrine FGF signaling<sup><xref rid="R4" ref-type="bibr">4</xref></sup>. In contrast to HS, &#x003b1;Klotho molecules do not directly participate in the dimer interface (<xref ref-type="fig" rid="F5">Fig. 5g</xref>), but rather indirectly support HS-induced dimerization by enhancing 1:1 FGF23-FGFR1c binding affinity. Hence, it appears that FGF23 strikes a fine balance between losing a large amount of HS-binding affinity to enable its endocrine mode of action and retaining sufficient HS-binding affinity to allow HS-mediated dimerization of two 1:1:1 FGF23-FGFR1c-&#x003b1;Klotho complexes. These considerations do not formally exclude the possibility that 2:2:2:2 and 2:2:2:1 quaternary dimers might co-exist as a higher order cluster on the cell surface, as has been proposed for paracrine 2:2:2 and 2:2:1 FGF-FGFR1-HS dimers<sup><xref rid="R32" ref-type="bibr">32</xref></sup>.</p><p id="P18">FGF19 and FGF21, the other two endocrine FGFs, require &#x003b2;Klotho as an obligate co-receptor to bind and activate cognate FGFRs<sup><xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup> so as to mediate effects that regulate, for example, metabolic pathways involved in bile acid biosynthesis or fatty acid oxidation<sup><xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref></sup>. Based on the structural analysis and supporting cell-based data shown in <xref ref-type="fig" rid="F14">Extended Data Fig. 9</xref> and <xref ref-type="fig" rid="F15">10</xref>, we propose that &#x003b2;Klotho, similar to &#x003b1;Klotho, functions as a non-enzymatic molecular scaffold to promote signaling by these two FGF hormones.</p></sec><sec id="S6"><title>Extended Data</title><fig id="F6" orientation="portrait" position="anchor"><label>Extended Data Figure 1</label><caption><title>&#x003b1;Klotho<sup>ecto</sup> functions as a coreceptor for FGF23</title><p id="P19">(<bold>a</bold>) Domain organization of membrane-bound &#x003b1;Klotho (&#x003b1;Klotho&#x02122;) and its soluble isoform &#x003b1;Klotho<sup>ecto</sup> generated by an ectodomain shedding in the kidney<sup><xref rid="R38" ref-type="bibr">50</xref></sup>. KL1 and KL2: tandem domains with homology to family 1 glycosidases<sup><xref rid="R39" ref-type="bibr">51</xref></sup>. (<bold>b</bold>) Representative immunoblots of phosphorylated ERK (top blots) and total ERK (bottom blots; sample loading control) in total HEK293 cell lysates (n=3 independent experiments). Upper panel: lysates from untransfected HEK293 cells that were pre-treated with a fixed &#x003b1;Klotho<sup>ecto</sup> concentration (10 nM) and then stimulated with increasing FGF23 concentrations, and lysates from HEK293-&#x003b1;Klotho&#x02122; cells treated with increasing concentrations of FGF23 alone. Lower panel: lysates from HEK293-&#x003b1;Klotho&#x02122; cells that were pre-treated with increasing &#x003b1;Klotho<sup>ecto</sup> concentrations and then stimulated with a fixed FGF23 concentration. (<bold>c</bold>) Plasma phosphate, fractional excretion of phosphate, and phosphate excretion rate in wild-type mice before and after a single injection of &#x003b1;Klotho<sup>ecto</sup> (0.1 mg/kg BW) or isotonic saline alone (buffer). Circles: mean values; error bars: SD; n=10 mice per group; * p &#x0003c; 0.05, paired Student&#x02019;s <italic>t</italic> test. (<bold>d</bold>) Relative Egr1 mRNA levels in the kidney of wild-type mice after a single injection with &#x003b1;Klotho<sup>ecto</sup> (0.1 mg/kg BW) or isotonic saline alone (buffer). Bars: mean values; error bars: SD; n=3 mice per group. The same batch of &#x003b1;Klotho<sup>ecto</sup> protein was used in the experiments shown in panels (<bold>b</bold>) to (<bold>d</bold>).</p></caption><graphic xlink:href="nihms927628f6"/></fig><fig id="F7" orientation="portrait" position="anchor"><label>Extended Data Figure 2</label><caption><title>Topology of ternary complex is consistent with its orientation on the cell surface</title><p id="P20">(<bold>a</bold>) Cartoon representation of 1:1:1 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex in four different orientations related by 90&#x000b0; rotation. &#x003b1;Klotho domains are colored cyan (KL1) and blue (KL2); KL1-KL2 linker is in yellow. FGFR1c and FGF23 are in green and orange, respectively. The ternary complex resembles an oblique rectangular prism with an average dimension of 100 &#x000c5; &#x000d7; 90 &#x000c5; &#x000d7; 50 &#x000c5;. The long axes of &#x003b1;Klotho<sup>ecto</sup> and FGF23-FGFR1c complex in the ternary complex are each about 90 &#x000c5; long, and parallel to one another such that the C-termini of FGFR1c<sup>ecto</sup> and &#x003b1;Klotho<sup>ecto</sup> end up on the same side of the ternary complex, ready to insert into the cell membrane (gray bar). First N-acetyl glucosamine moiety (purple sticks) at six of the seven consensus N-linked &#x003b1;Klotho glycosylation sites could be built due to sufficient electron density. Asn-694 is the only glycosylation site that falls in the vicinity of a binding interface, namely &#x003b1;Klotho<sup>ecto</sup>&#x02013;FGF23. (<bold>b</bold>) Close-up view of KL1-KL2 interdomain interface. Zinc (orange sphere)-mediated contacts facilitate overall &#x003b1;Klotho<sup>ecto</sup> conformation. Dashed yellow lines: hydrogen bonds; gray surfaces: hydrophobic contacts. (<bold>c</bold>) Emission energy spectrum obtained from excitation/emission scan of FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> crystal. Inset: expanded view of zinc fluorescence at 8,637 eV of emission energy.</p></caption><graphic xlink:href="nihms927628f7"/></fig><fig id="F8" orientation="portrait" position="anchor"><label>Extended Data Figure 3</label><caption><title>Structural basis for FGF23&#x02019;s weak FGFR-binding affinity</title><p id="P21">(<bold>a</bold>) Open-book view of FGF23-FGFR1c<sup>ecto</sup> complex interface. FGF23 (orange) and FGFR1c<sup>ecto</sup> (green) are pulled apart and rotated by 90&#x000b0; around the vertical axis to expose the binding interface (blue). (<bold>b</bold>) Ligand&#x02013;receptor D3 and ligand&#x02013;receptor D2-D3 linker interfaces of endocrine FGF23-FGFR1c and paracrine FGF9-FGFR1c<sup><xref rid="R40" ref-type="bibr">52</xref></sup> structures. Gray transparent surfaces: hydrophobic interactions; dashed yellow lines: hydrogen bonds. Because FGF9 Arg-62 is replaced with glycine in FGF23 (Gly-38) and FGF9 Glu-138 is replaced with histidine in FGF23 (His-117), neither the side chain of Asp-125 in FGF23 (Asn-146 in FGF9), nor the side chain of invariant Arg-250 in the FGFR1c D2-D3 linker can be tethered through intramolecular hydrogen bonds. Thus, these side chains possess greater freedom of motion in the FGF23-FGFR1c complex, and as a result, hydrogen bonding between FGF23 and FGFR1c D2-D3 linker entails greater entropic cost, which generates less binding affinity. Substitution of Phe-140 and Pro-189 in FGF9 with hydrophilic Thr-119 and Ser-159 in FGF23 further diminishes the ability of FGF23 to gain binding affinity from hydrogen bonding with FGFR1c D2-D3 linker. A lack of contacts between FGF23 N-terminus and FGFR1c D3 cleft, which forms between alternatively spliced &#x003b2;C&#x02019;-&#x003b2;E and &#x003b2;B&#x02019;-&#x003b2;C loops<sup><xref rid="R41" ref-type="bibr">53</xref></sup>, likely further exacerbates FGF23&#x02019;s weak FGFR-binding affinity. (<bold>c</bold>) Ligand&#x02013;receptor D2 interface in endocrine FGF23-FGFR1c and paracrine FGF9-FGFR1c<sup><xref rid="R40" ref-type="bibr">52</xref></sup> structures. Gray transparent surfaces: hydrophobic interactions; dashed yellow lines: hydrogen bonds. Many contacts at this interface are conserved between paracrine FGFs and FGF23, and hence FGF23 gains much of its FGFR-binding affinity through these contacts. Three hydrogen bonds involving Asn-49, Ser-50, and His-66 of FGF23 are unique to the FGF23-FGFR1c complex.</p></caption><graphic xlink:href="nihms927628f8"/></fig><fig id="F9" orientation="portrait" position="anchor"><label>Extended Data Figure 4</label><caption><title>Structural basis for FGFR isoform specificity of &#x003b1;Klotho and FGF23</title><p id="P22">(<bold>a</bold>) Structure-based sequence alignment of a segment of FGFR D3. The alternatively spliced regions of all seven FGFRs are boxed with a purple rectangle. &#x003b2; strand locations above the alignment are colored green (constant region) and purple (alternatively spliced region). A leucine (boxed) of hydrophobic groove residues (light purple) in the alternatively spliced region is conserved only among &#x0201c;c&#x0201d; isoforms of FGFR1-3 and FGFR4, which explains &#x003b1;Klotho binding selectivity for these receptors. (<bold>b</bold>) Interface between FGF23 and &#x003b2;F-&#x003b2;G loop of FGFR1c D3 in the FGF23-FGFR1c structure of the ternary complex. Backbone atoms of His-117 and Gly-81 in FGF23 make specific hydrogen bonds with Ser-346 side-chain and Asn-345 backbone atoms of the &#x003b2;F-&#x003b2;G loop. Serine corresponding to Ser-346 in FGFR1c (yellow) is conserved only among &#x0201c;c&#x0201d; isoforms of FGFR1-3 and FGFR4 (see panel <bold>a</bold>). (<bold>c</bold>) Representative immunoblots of phosphorylated ERK (top blot) and total ERK (bottom blot; sample loading control) in total BaF3 cell lysates (n=3 independent experiments). (<bold>d</bold>) Cartoon representations of four paracrine FGF-FGFR complex structures<sup><xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R4" ref-type="bibr">4</xref></sup>. Solid black oval: hydrophobic D3 groove. Dashed black circle: second binding pocket (SBP) for &#x003b1;Klotho in D3. While the hydrophobic groove is engaged by FGF8 (see also panel <bold>e</bold>), the SBP is not utilized in any of the current paracrine FGF-FGFR structures. In most paracrine FGF-FGFR structures, the &#x003b2;C-&#x003b2;C&#x02019; loop is disordered (dashed red lines) since it does not participate in FGF binding. Evidently, SBP and &#x003b2;C-&#x003b2;C&#x02019; loop in D3 have evolved to mediate &#x003b1;Klotho binding to FGFR. (<bold>e</bold>) &#x003b1;Klotho and FGF8b both bind to the hydrophobic groove in FGFR1c D3. FGF8b (brown) from the FGF8b-FGFR2c structure<sup><xref rid="R3" ref-type="bibr">3</xref></sup> was superimposed onto FGF23 in the FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex. The &#x003b1;N helix of FGF8b occupies the same binding pocket in FGFR1c D3 as the distal tip of &#x003b1;Klotho RBA.</p></caption><graphic xlink:href="nihms927628f9"/></fig><fig id="F10" orientation="portrait" position="anchor"><label>Extended Data Figure 5</label><caption><title>&#x003b1;Klotho is the first non-enzymatic scaffold among TIM barrel proteins</title><p id="P23">(<bold>a</bold>) Structure-based sequence alignment of TIM barrels of &#x003b1;Klotho KL1 and KL2 domains and <underline>Kl</underline>otho <underline>R</underline>elated <underline>P</underline>rotein (KLrP). Most glycoside hydrolases (GH), a functionally diverse group of enzymes that cleave glycosidic bonds of complex carbohydrates on glycoproteins<sup><xref rid="R39" ref-type="bibr">51</xref></sup>, adopt TIM barrel fold. Locations and lengths of TIM barrel &#x003b2;-strands and &#x003b1;-helices are indicated above the alignment. Among GH family 1 members of the Klotho subfamily, only KLrP has a verified glycosylceramidase activity<sup><xref rid="R42" ref-type="bibr">54</xref></sup>, and E165 and E373 are its catalytically essential glutamic acids. KLrP residues colored cyan participate in substrate recognition/hydrolysis. &#x003b1;Klotho residues colored red bind FGF23, and &#x003b1;Klotho residues of the KL2 &#x003b2;1&#x003b1;1 loop (purple box) colored purple interact with the FGFR1c D3 domain. (<bold>b</bold>) Superimposition of KL1 C&#x003b1; trace (gray/cyan) onto that of KLrP (gray/yellow). Superimposition RMSD is 1.08 &#x000c5;. Structurally most divergent regions between KL1 and KLrP are in cartoon representation. Glucose moiety and aliphatic chains of glucosylceramide (KLrP substrate) are in sticks with carbon in black (glucose) or green/cyan/pink (aliphatic chains). Catalytically essential Glu-165 in KLrP is replaced by an asparagine in KL1. Hydrophobic residues from KL1 &#x003b2;6-&#x003b1;6 loop occupy the pocket that accommodates the aliphatic chains of glucosylceramide in KLrP. KL1 N-terminus supports KL1-KL2 cleft formation (<xref ref-type="fig" rid="F7">Extended Data Fig. 2b</xref>) and KL1 &#x003b2;6-&#x003b1;6 loop conformation contributes to a key portion of the binding pocket in this cleft for the FGF23 C-terminal tail (<xref ref-type="fig" rid="F3">Fig. 3c</xref>). (<bold>c&#x02013;d</bold>) Superimposition of KL2 C&#x003b1; trace (gray/blue) onto that of KLrP (gray/yellow). Superimposition RMSD is 1.37 &#x000c5;. Structurally divergent &#x003b2;1&#x003b1;1 (<bold>c</bold>), &#x003b2;6&#x003b1;6 and &#x003b2;8&#x003b1;8 (<bold>d</bold>) loops of KL2 and KLrP are rendered in cartoon. &#x003b2;1&#x003b1;1 loop in KL2 is disengaged from the central TIM barrel and stretches away from it by as much as 35 &#x000c5;. Catalytically essential Glu-373 in KLrP is replaced by a serine in KL2. KLrP residues from &#x003b2;6&#x003b1;6 and &#x003b2;8&#x003b1;8 loops bind glucosylceramide (KLrP substrate); for example, W345 in the &#x003b2;6&#x003b1;6 loop and E424 and W425 in the &#x003b2;8&#x003b1;8 loop. Sequence divergence (panel <bold>a</bold>) and altered loop conformations are incompatible with glucosylceramide coordination by KL2. &#x003b2;1&#x003b1;1, &#x003b2;6&#x003b1;6 and &#x003b2;8&#x003b1;8 loops lie at the rim of the catalytic mouth in the TIM barrel (see <xref ref-type="fig" rid="F2">Fig. 2b</xref>). Divergent conformations of these three loops in KL2 result in significant widening of the central barrel cavity in KL2, which merges with the KL1-KL2 cleft to form an expansive basin that accommodates the distal portion of the FGF23 C-terminal tail.</p></caption><graphic xlink:href="nihms927628f10"/></fig><fig id="F11" orientation="portrait" position="anchor"><label>Extended Data Figure 6</label><caption><title>&#x003b1;Klotho interaction with rigid core of FGF23 and a second binding pocket next to the hydrophobic groove in FGFR1c D3</title><p id="P24">(<bold>a</bold>) A partial view of the ternary complex. &#x003b1;Klotho<sup>ecto</sup> (cyan/blue solid surface, receptor binding arm (RBA) of KL2 in blue cartoon), FGF23 (orange transparent surface and cartoon), FGFR1c (constant region: solid green surface; alternatively splice region: solid purple surface). Dashed black circle: perimeter of the interface between proximal end of &#x003b1;Klotho RBA and a second binding pocket (SBP) in FGFR1c D3 next to the hydrophobic groove. Solid black box: perimeter of &#x003b1;Klotho&#x02212;FGF23<sup>core</sup> interface. (<bold>b</bold>) Close-up view of the interface between proximal end of RBA and SBP in D3. Disulfide bridge between Cys-572 (N-terminal end of RBA) and Cys-621 (&#x003b1;2 helix) at the base of the RBA likely imparts some degree of conformational rigidity to the proximal RBA portion, whereas the conformation of the distal RBA tip is dictated by contacts with FGFR1c D3. (<bold>c</bold>) Close-up view of the &#x003b1;Klotho&#x02212;FGF23<sup>core</sup> interface detailing hydrogen bonding (upper panel) and hydrophobic contacts (lower panel). Gray transparent surfaces: hydrophobic interactions; dashed yellow lines: hydrogen bonding contacts.</p></caption><graphic xlink:href="nihms927628f11"/></fig><fig id="F12" orientation="portrait" position="anchor"><label>Extended Data Figure 7</label><caption><title>Deletion of receptor binding arm of &#x003b1;Klotho<sup>ecto</sup> generates an FGF23 ligand trap</title><p id="P25">(<bold>a</bold>) Plasma phosphate and fractional excretion of phosphate in wild-type mice before and after a single injection of &#x003b1;Klotho<sup>ecto</sup> (0.1 mg/kg BW), mutant &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> (0.1 mg/kg BW), or isotonic saline alone (buffer). Circles: mean values; error bars: SD; n=6 mice per group; p: significance value determined by a paired Student&#x02019;s <italic>t</italic> test. (<bold>b</bold>) Relative Egr1 mRNA levels in the kidney of wild-type mice injected once with &#x003b1;Klotho<sup>ecto</sup> (0.1 mg/kg BW; n=3), mutant &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> (0.1 mg/kg BW; n=4), or isotonic saline alone (buffer; n=3). Bars: mean values; error bars: SD. (<bold>c</bold>) Representative elution profiles of FGF23/&#x003b1;Klotho<sup>ecto</sup> and FGF23/&#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> mixtures from a size-exclusion column and representative Coomassie Brilliant Blue-stained SDS-polyacrylamide gels of eluted protein peak fractions. (<bold>d</bold>) Thermal shift assay of &#x003b1;Klotho<sup>ecto</sup> and &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> mutant in the presence and absence of FGF23 C-terminal tail peptide (FGF23<sup>C-tail</sup>) (n=3 independent experiments). Increased melting temperatures in the presence of the FGF23<sup>C-tail</sup> indicate interaction of both &#x003b1;Klotho<sup>ecto</sup> proteins with the peptide. Higher melting temperature of &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> mutant relative to wild-type &#x003b1;Klotho<sup>ecto</sup> indicates greater stability of the mutant protein. (<bold>e</bold>) Representative immunoblots of phosphorylated ERK (top blot) and total ERK (bottom blot; sample loading control) in total lysates from HEK293-&#x003b1;Klotho&#x02122; cells co-stimulated with a fixed FGF23 concentration and increasing &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> concentrations (n=3 independent experiments). &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> mutant inhibits FGF23-induced ERK phosphorylation due to sequestering FGF23 into inactive FGF23-&#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> binary complexes. This also explains why &#x003b1;Klotho<sup>ecto/&#x00394;RBA</sup> injection into mice causes an increase in plasma phosphate (panel <bold>a</bold>) concomitant with renal Egr1 gene repression (panel <bold>b</bold>).</p></caption><graphic xlink:href="nihms927628f12"/></fig><fig id="F13" orientation="portrait" position="anchor"><label>Extended Data Figure 8</label><caption><title>FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup>-HS quaternary dimer models</title><p id="P26">(<bold>a</bold>) A 2:2:2:1 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup>-HS quaternary dimer in two orientations related by a 90&#x000b0; rotation around the horizontal axis. The dimer was constructed by superimposing FGF23 from two copies of 1:1:1 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex onto the two FGF1 molecules in the 2:2:1 FGF1-FGFR2c-HS dimer<sup><xref rid="R43" ref-type="bibr">55</xref>&#x02013;<xref rid="R46" ref-type="bibr">58</xref></sup>. The dimer is held together solely by HS, which bridges two FGF23 molecules in <italic>trans</italic>. Boxed pink surface: location of Ala-171, Ile-203, and Val-221 of FGFR1c, the mutation of which impairs the ability of HS to induce 2:2:2:2 quaternary dimer formation (<xref ref-type="fig" rid="F5">Fig. 5f</xref>). Boxed gray region: location of Met-149, Asn-150, and Pro-151 of FGF23, the mutation of which diminishes HS-induced quaternary dimerization (<xref ref-type="fig" rid="F5">Fig. 5e and 5f</xref>). None of these residues plays any role in 2:2:2:1 quaternary dimer formation, and hence, contrary to experimental evidence (<xref ref-type="fig" rid="F5">Fig. 5</xref>), mutation of these residues should not impact HS-induced FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> dimerization. (<bold>b</bold>) A 2:2:2:2 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup>-HS quaternary dimer in two orientations related by a 90&#x000b0; rotation around the horizontal axis. See also <xref ref-type="fig" rid="F5">Fig. 5g</xref>. The dimer was constructed by superimposing FGF23 from two copies of 1:1:1 FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex onto the two FGF2 molecules in the 2:2:2 FGF2-FGFR1c-HS dimer<sup><xref rid="R47" ref-type="bibr">59</xref></sup>. Insets: close-up views of the secondary FGF-FGFR (upper inset) and direct FGFR-FGFR (lower inset) interfaces. Gray/pink transparent surfaces: hydrophobic interactions. Mutation of Ala-171, Ile-203, and Val-221 (pink) impairs the ability of HS to dimerize FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> ternary complex (<xref ref-type="fig" rid="F5">Fig. 5f</xref>).</p></caption><graphic xlink:href="nihms927628f13"/></fig><fig id="F14" orientation="portrait" position="anchor"><label>Extended Data Figure 9</label><caption><title>FGF19/FGF21 co-receptor &#x003b2;Klotho is a non-enzymatic scaffold protein analogous to &#x003b1;Klotho</title><p id="P27">Structure-based sequence alignment of &#x003b1;Klotho and &#x003b2;Klotho. The locations of the eight alternating &#x003b2;-strands and &#x003b1;-helices of the TIM fold are indicated above the alignment. Cyan, blue, and yellow bars below the alignment mark the domain boundaries of KL1, KL2, and KL1-KL2 linker. Asterisks denote sequence identity and dots denote sequence similarity. Scissor symbols mark the four proposed sites of &#x003b1;Klotho cleavage by ADAM proteases/secretases. Cleavage 1, which coincides with the end of the rigid core of KL2, results in shedding of the entire &#x003b1;Klotho ectodomain from the cell membrane. While this cleavage product is a functional co-receptor, the &#x003b1;Klotho fragments generated by cleavages 2, 3, and 4 would be devoid of co-receptor activity. Black triangle: site where alternative splicing replaces the C-terminal KL2 sequence with a 15-residue-long unrelated sequence. Glycan chain symbols: seven predicted N-linked glycosylation sites. Zn<sup>2+</sup>-chelating residues of &#x003b1;Klotho are green, FGFR1c-binding residues are light purple, and FGF23-binding residues are red. Light purple box: &#x003b2;1&#x003b1;1 loop sequence in KL2 termed RBA. &#x003b2;Klotho RBA is about as long as &#x003b1;Klotho RBA, and key FGFR-binding residues are conserved between these two RBAs, which is consistent with the similar FGFR-binding specificity of &#x003b1;Klotho and &#x003b2;Klotho<sup><xref rid="R48" ref-type="bibr">60</xref>,<xref rid="R49" ref-type="bibr">61</xref></sup>. But &#x003b1;Klotho residues in the binding pockets for the FGF23 C-terminal tail are not conserved in &#x003b2;Klotho, conforming to major sequence differences between the C-terminal tails of FGF23 and FGF19/FGF21 (<xref ref-type="fig" rid="F15">Extended Data Fig. 10a</xref>).</p></caption><graphic xlink:href="nihms927628f14"/></fig><fig id="F15" orientation="portrait" position="anchor"><label>Extended Data Figure 10</label><caption><title>&#x003b2;Klotho-dependent FGFR activation by FGF19/FGF21 is mechanistically similar to &#x003b1;Klotho-dependent FGFR activation by FGF23</title><p id="P28">(<bold>a</bold>) Structure-based sequence alignment of endocrine FGFs. &#x003b2;-strands and &#x003b1;C helix comprising the atypical &#x003b2;-trefoil core of FGF23 are indicated above the alignment. Asterisks and dots below the alignment denote sequence identity and similarity, respectively. Scissor symbols mark inactivating proteolytic cleavage sites in FGF23 and FGF21<sup><xref rid="R50" ref-type="bibr">62</xref></sup>. RXXR cleavage motif in FGF23 is in green bold letters. FGFR1c-binding residues of FGF23 are colored blue, &#x003b1;Klotho-binding residues are colored red. Vertical blue arrow marks the C-terminal boundary of the FGF23 variant used to solve the FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex structure. Five residues at the distal C-terminal region of FGF19/FGF21 (black/gray) mediate binding of FGF19/FGF21 to &#x003b2;Klotho. These residues completely diverge from the &#x003b1;Klotho-binding residues in the FGF23 C-terminal tail. &#x003b1;Klotho-binding residues in the FGF23 core also are not conserved in FGF19/FGF21. (<bold>b</bold>) Representative immunoblots of phosphorylated ERK (top blot) and total ERK (bottom blot; sample loading control) in total lysates from HEK293 cells expressing wild-type or mutant &#x003b2;Klotho&#x02122; (n=3 independent experiments). Similar to &#x003b1;Klotho<sup>&#x00394;RBA</sup>, &#x003b2;Klotho<sup>&#x00394;RBA</sup> failed to support FGF21-induced FGFR activation, and &#x003b2;Klotho<sup>L394P</sup> and &#x003b2;Klotho<sup>M435Y</sup> mutants also had greatly diminished ability to promote FGF21 signaling. Thus, &#x003b2;Klotho tethers FGFR1c and FGF21 to itself in a manner similar to that identified for &#x003b1;Klotho to enable FGF21 signaling. (<bold>c</bold>) Representative immunoblots of phosphorylated ERK (top blot) and total ERK (bottom blot; sample loading control) in total lysates from BaF3 cells expressing FGFR1c and &#x003b2;Klotho&#x02122; (n=3 independent experiments). Like &#x003b1;Klotho, &#x003b2;Klotho also requires heparin to support FGF21-mediated FGFR1c activation.</p></caption><graphic xlink:href="nihms927628f15"/></fig><table-wrap id="T1" position="anchor" orientation="portrait"><label>Extended Data Table 1</label><caption><p id="P29">X-ray Data Collection, Structure Refinement Statistics Values in parenthesis are for the highest resolution shell.</p></caption><table frame="box" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Protein</th><th align="center" rowspan="1" colspan="1">FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup></th></tr></thead><tbody><tr><td align="center" colspan="2" rowspan="1"><bold><italic>Data Collection</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">X-ray wavelength (&#x000c5;)</td><td align="center" rowspan="1" colspan="1">0.97918</td></tr><tr><td align="left" rowspan="1" colspan="1">Space group</td><td align="center" rowspan="1" colspan="1">C2</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="center" colspan="2" rowspan="1"><bold><italic>Unit Cell Dimensions</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">a, b, c (&#x000c5;)</td><td align="center" rowspan="1" colspan="1">283.31, 72.60, 95.33</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;, &#x003b2;, &#x003b3; (&#x000b0;)</td><td align="center" rowspan="1" colspan="1">90.00, 91.98, 90.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td align="center" rowspan="1" colspan="1">50&#x02013;3.00 (3.18&#x02013;3.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">No. measured reflections</td><td align="center" rowspan="1" colspan="1">294862</td></tr><tr><td align="left" rowspan="1" colspan="1">No. unique reflections</td><td align="center" rowspan="1" colspan="1">39077</td></tr><tr><td align="left" rowspan="1" colspan="1">Data redundancy</td><td align="center" rowspan="1" colspan="1">7.5 (7.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Data completeness (%)</td><td align="center" rowspan="1" colspan="1">99.7 (98.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">R<sub>meas</sub> (%)</td><td align="center" rowspan="1" colspan="1">20.7 (138.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Signal (&#x0003c;I/&#x003c3;I&#x0003e;)</td><td align="center" rowspan="1" colspan="1">11.1 (1.7)</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="center" colspan="2" rowspan="1"><bold><italic>Refinement</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td align="center" rowspan="1" colspan="1">48.81&#x02013;3.00 (3.08&#x02013;3.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">No. unique reflections</td><td align="center" rowspan="1" colspan="1">39042 (2766)</td></tr><tr><td align="left" rowspan="1" colspan="1">No. reflections (R<sub>free</sub>)</td><td align="center" rowspan="1" colspan="1">1954 (137)</td></tr><tr><td align="left" rowspan="1" colspan="1">R<sub>work</sub>/R<sub>free</sub></td><td align="center" rowspan="1" colspan="1">23.72 (45.41)/29.68 (53.68)</td></tr><tr><td align="left" rowspan="1" colspan="1">No. TLS groups</td><td align="center" rowspan="1" colspan="1">3 (one per polypeptide chain)</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="center" colspan="2" rowspan="1"><bold><italic>Number of atoms</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Protein</td><td align="center" rowspan="1" colspan="1">10466</td></tr><tr><td align="left" rowspan="1" colspan="1">Sugar (NAG)</td><td align="center" rowspan="1" colspan="1">98</td></tr><tr><td align="left" rowspan="1" colspan="1">Glutathione (GSH)</td><td align="center" rowspan="1" colspan="1">40</td></tr><tr><td align="left" rowspan="1" colspan="1">Ion (Zn<sup>2+</sup>)</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Solvent</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="center" colspan="2" rowspan="1"><bold><italic>R.m.s. deviations</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Bond length (&#x000c5;)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Bond angle (&#x000b0;)</td><td align="center" rowspan="1" colspan="1">0.498</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="center" colspan="2" rowspan="1"><bold><italic>Average B factors (&#x000c5;<sup>2</sup>)</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Protein</td><td align="center" rowspan="1" colspan="1">114</td></tr><tr><td align="left" rowspan="1" colspan="1">Sugar (NAG)</td><td align="center" rowspan="1" colspan="1">180</td></tr><tr><td align="left" rowspan="1" colspan="1">Glutathione (GSH)</td><td align="center" rowspan="1" colspan="1">170</td></tr><tr><td align="left" rowspan="1" colspan="1">Ion (Zn<sup>2+</sup>)</td><td align="center" rowspan="1" colspan="1">116</td></tr><tr><td align="left" rowspan="1" colspan="1">Solvent</td><td align="center" rowspan="1" colspan="1">58</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="center" colspan="2" rowspan="1"><bold><italic>Ramachandran Plot</italic></bold></td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Favored (%)</td><td align="center" rowspan="1" colspan="1">89.39</td></tr><tr><td align="left" rowspan="1" colspan="1">Allowed (%)</td><td align="center" rowspan="1" colspan="1">9.60</td></tr><tr><td align="left" rowspan="1" colspan="1">Outliers (%)</td><td align="center" rowspan="1" colspan="1">1.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Rotamer outliers (%)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">No. C&#x003b2; Deviations</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">All-Atom Clashscore</td><td align="center" rowspan="1" colspan="1">7.7</td></tr><tr><td align="left" colspan="2" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>PDB ID</italic></bold></td><td align="center" rowspan="1" colspan="1">5W21</td></tr></tbody></table></table-wrap></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS927628-supplement-1.pdf" orientation="portrait" xlink:type="simple" id="d36e1770" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>2</label><media xlink:href="NIHMS927628-supplement-2.docx" orientation="portrait" xlink:type="simple" id="d36e1774" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>3</label><media xlink:href="NIHMS927628-supplement-3.pdf" orientation="portrait" xlink:type="simple" id="d36e1778" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Supplementary Table 1</label><media xlink:href="NIHMS927628-supplement-Supplementary_Table_1.pdf" orientation="portrait" xlink:type="simple" id="d36e1782" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplementary Table 2</label><media xlink:href="NIHMS927628-supplement-Supplementary_Table_2.pdf" orientation="portrait" xlink:type="simple" id="d36e1786" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><media xlink:href="NIHMS927628-supplement-supplement_1.pdf" orientation="portrait" xlink:type="simple" id="d36e1788" position="anchor"/></supplementary-material></sec></body><back><ack id="S7"><p id="P30">We thank Dr. Nicholas J. Cowan for critically reading and editing the manuscript, and Dr. Ching-Shin Huang for help with diffraction data processing with XDS. This work was primarily supported by NIH grant R01 DE13686 (to M.M.). Support was also provided by National Key R&#x00026;D Program of China (#2017YFA0506000 to X.L.). Funding for mouse studies was provided by R01 DK092461, P30 DK079328 (to O.W.M.), and R01 DK091392 (to M.C.H). Beamlines at the Northeastern Collaborative Access Team (NE-CAT) facility at the Advanced Photon Source of Argonne National Laboratory are primarily funded by NIH NIGMS and member institutions.</p></ack><fn-group><fn fn-type="COI-statement" id="FN4"><p id="P31"><bold>Competing financial interests</bold></p><p id="P32">O.W.M. has done paid consultation for AbbVie, Allena, Amgen, and Tricida. He also sits on the board of Klotho Therapeutics. All the other authors have no competing financial interests to declare.</p></fn><fn id="FN5" fn-type="con"><p id="P33"><bold>Author contribution statement</bold></p><p id="P34">G.C. purified and crystallized the ternary complex, analyzed the crystal structure, generated SEC-MALS data (<xref ref-type="fig" rid="F4">Figures 4a</xref>, <xref ref-type="fig" rid="F5">5a, b, f</xref>), cell-based data (<xref ref-type="fig" rid="F4">Figure 4</xref>), enzyme and thermostability assay data (<xref ref-type="fig" rid="F2">Figure 2c</xref>), and participated in designing experiments and writing/revising the manuscript. Y.L. helped with data collection and analysis of the crystal structure, generated cell-based data (<xref ref-type="fig" rid="F5">Figure 5</xref>), and participated in manuscript revision. R.G. established expression/purification protocols for the ternary complex, performed ternary complex characterization, analyzed mouse data, and participated in editing/revising the manuscript. L.F. generated expression constructs for FGF23, FGFR1c<sup>ecto</sup>, &#x003b1;Klotho<sup>ecto</sup> and their structure-based mutated forms, and helped with ternary complex purification. S.J. assisted with diffraction data collection and did excitation/emission scanning of the FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> crystal (<xref ref-type="fig" rid="F7">Extended Data Figure 2c</xref>). M-C.H. and O.W.M. generated the mouse data (<xref ref-type="fig" rid="F6">Extended Data Figures 1c,d</xref> and <xref ref-type="fig" rid="F12">7a,b</xref>). G.L. and X.L. (G.C. and L. F.&#x02019;s mentors in their home institution, Wenzhou Medical University) participated in manuscript revision. M.M. developed/directed the project, solved/refined/analyzed/interpreted the crystal structure of the ternary complex, and wrote the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimada</surname><given-names>T</given-names></name><etal/></person-group><article-title>Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism</article-title><source>J Clin Invest</source><volume>113</volume><fpage>561</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1172/JCI19081</pub-id><year>2004</year><pub-id pub-id-type="pmid">14966565</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gattineni</surname><given-names>J</given-names></name><etal/></person-group><article-title>FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1</article-title><source>Am J Physiol Renal Physiol</source><volume>297</volume><fpage>F282</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.90742.2008</pub-id><year>2009</year><pub-id pub-id-type="pmid">19515808</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmon</surname><given-names>MA</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name></person-group><article-title>Cell signaling by receptor tyrosine kinases</article-title><source>Cell</source><volume>141</volume><fpage>1117</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.06.011</pub-id><year>2010</year><pub-id pub-id-type="pmid">20602996</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlessinger</surname><given-names>J</given-names></name><etal/></person-group><article-title>Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization</article-title><source>Mol Cell</source><volume>6</volume><fpage>743</fpage><lpage>750</lpage><year>2000</year><pub-id pub-id-type="pmid">11030354</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>Olsen</surname><given-names>SK</given-names></name><name><surname>Ibrahimi</surname><given-names>OA</given-names></name></person-group><article-title>Structural basis for fibroblast growth factor receptor activation</article-title><source>Cytokine Growth Factor Rev</source><volume>16</volume><fpage>107</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2005.01.008</pub-id><year>2005</year><pub-id pub-id-type="pmid">15863029</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>R</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>Exploring mechanisms of FGF signalling through the lens of structural biology</article-title><source>Nat Rev Mol Cell Biol</source><volume>14</volume><fpage>166</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1038/nrm3528</pub-id><year>2013</year><pub-id pub-id-type="pmid">23403721</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuro-o</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mutation of the mouse klotho gene leads to a syndrome resembling ageing</article-title><source>Nature</source><volume>390</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/36285</pub-id><year>1997</year><pub-id pub-id-type="pmid">9363890</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrissat</surname><given-names>B</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name></person-group><article-title>Structural and sequence-based classification of glycoside hydrolases</article-title><source>Curr Opin Struct Biol</source><volume>7</volume><fpage>637</fpage><lpage>644</lpage><year>1997</year><pub-id pub-id-type="pmid">9345621</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>R</given-names></name><etal/></person-group><article-title>Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members</article-title><source>Mol Cell Biol</source><volume>27</volume><fpage>3417</fpage><lpage>3428</lpage><pub-id pub-id-type="doi">10.1128/MCB.02249-06</pub-id><year>2007</year><pub-id pub-id-type="pmid">17339340</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>R</given-names></name><etal/></person-group><article-title>Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation</article-title><source>Proc Natl Acad Sci U S A</source><volume>107</volume><fpage>407</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1073/pnas.0902006107</pub-id><year>2010</year><pub-id pub-id-type="pmid">19966287</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urakawa</surname><given-names>I</given-names></name><etal/></person-group><article-title>Klotho converts canonical FGF receptor into a specific receptor for FGF23</article-title><source>Nature</source><volume>444</volume><fpage>770</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1038/nature05315</pub-id><year>2006</year><pub-id pub-id-type="pmid">17086194</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Regulation of fibroblast growth factor-23 signaling by klotho</article-title><source>J Biol Chem</source><volume>281</volume><fpage>6120</fpage><lpage>6123</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500457200</pub-id><year>2006</year><pub-id pub-id-type="pmid">16436388</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice</article-title><source>Cell Struct Funct</source><volume>29</volume><fpage>91</fpage><lpage>99</lpage><year>2004</year><pub-id pub-id-type="pmid">15665504</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Loon</surname><given-names>EP</given-names></name><etal/></person-group><article-title>Shedding of klotho by ADAMs in the kidney</article-title><source>Am J Physiol Renal Physiol</source><volume>309</volume><fpage>F359</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00240.2014</pub-id><year>2015</year><pub-id pub-id-type="pmid">26155844</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>K</given-names></name><etal/></person-group><article-title>The kidney is the principal organ mediating klotho effects</article-title><source>J Am Soc Nephrol</source><volume>25</volume><fpage>2169</fpage><lpage>2175</lpage><pub-id pub-id-type="doi">10.1681/ASN.2013111209</pub-id><year>2014</year><pub-id pub-id-type="pmid">24854271</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CD</given-names></name><name><surname>Podvin</surname><given-names>S</given-names></name><name><surname>Gillespie</surname><given-names>E</given-names></name><name><surname>Leeman</surname><given-names>SE</given-names></name><name><surname>Abraham</surname><given-names>CR</given-names></name></person-group><article-title>Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>19796</fpage><lpage>19801</lpage><pub-id pub-id-type="doi">10.1073/pnas.0709805104</pub-id><year>2007</year><pub-id pub-id-type="pmid">18056631</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imura</surname><given-names>A</given-names></name><etal/></person-group><article-title>Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane</article-title><source>FEBS Lett</source><volume>565</volume><fpage>143</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2004.03.090</pub-id><year>2004</year><pub-id pub-id-type="pmid">15135068</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein</article-title><source>Biochem Biophys Res Commun</source><volume>242</volume><fpage>626</fpage><lpage>630</lpage><year>1998</year><pub-id pub-id-type="pmid">9464267</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiraki-Iida</surname><given-names>T</given-names></name><etal/></person-group><article-title>Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein</article-title><source>FEBS Lett</source><volume>424</volume><fpage>6</fpage><lpage>10</lpage><year>1998</year><pub-id pub-id-type="pmid">9537505</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Suppression of aging in mice by the hormone Klotho</article-title><source>Science</source><volume>309</volume><fpage>1829</fpage><lpage>1833</lpage><pub-id pub-id-type="doi">10.1126/science.1112766</pub-id><year>2005</year><pub-id pub-id-type="pmid">16123266</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>MC</given-names></name><name><surname>Shiizaki</surname><given-names>K</given-names></name><name><surname>Kuro-o</surname><given-names>M</given-names></name><name><surname>Moe</surname><given-names>OW</given-names></name></person-group><article-title>Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism</article-title><source>Annu Rev Physiol</source><volume>75</volume><fpage>503</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-030212-183727</pub-id><year>2013</year><pub-id pub-id-type="pmid">23398153</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel</article-title><source>Science</source><volume>310</volume><fpage>490</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1126/science.1114245</pub-id><year>2005</year><pub-id pub-id-type="pmid">16239475</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><fpage>9805</fpage><lpage>9810</lpage><pub-id pub-id-type="doi">10.1073/pnas.0803223105</pub-id><year>2008</year><pub-id pub-id-type="pmid">18606998</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule</article-title><source>Faseb Journal</source><volume>24</volume><fpage>3438</fpage><lpage>3450</lpage><pub-id pub-id-type="doi">10.1096/fj.10-154765</pub-id><year>2010</year><pub-id pub-id-type="pmid">20466874</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imura</surname><given-names>A</given-names></name><etal/></person-group><article-title>alpha-Klotho as a regulator of calcium homeostasis</article-title><source>Science</source><volume>316</volume><fpage>1615</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.1126/science.1135901</pub-id><year>2007</year><pub-id pub-id-type="pmid">17569864</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase</article-title><source>J Biol Chem</source><volume>282</volume><fpage>30889</fpage><lpage>30900</lpage><pub-id pub-id-type="doi">10.1074/jbc.M700832200</pub-id><year>2007</year><pub-id pub-id-type="pmid">17595169</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>R</given-names></name><etal/></person-group><article-title>Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands</article-title><source>Mol Cell Biol</source><volume>32</volume><fpage>1944</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1128/MCB.06603-11</pub-id><year>2012</year><pub-id pub-id-type="pmid">22451487</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrukhova</surname><given-names>O</given-names></name><etal/></person-group><article-title>Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis</article-title><source>J Bone Miner Res</source><volume>32</volume><fpage>2049</fpage><lpage>2061</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3195</pub-id><year>2017</year><pub-id pub-id-type="pmid">28600880</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><etal/></person-group><article-title>C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors</article-title><source>J Biol Chem</source><volume>283</volume><fpage>33304</fpage><lpage>33309</lpage><pub-id pub-id-type="doi">10.1074/jbc.M803319200</pub-id><year>2008</year><pub-id pub-id-type="pmid">18829467</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells</article-title><source>Mol Cell Biol</source><volume>12</volume><fpage>240</fpage><lpage>247</lpage><year>1992</year><pub-id pub-id-type="pmid">1309590</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>L</given-names></name><name><surname>Burke</surname><given-names>DF</given-names></name><name><surname>von Delft</surname><given-names>F</given-names></name><name><surname>Mulloy</surname><given-names>B</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name></person-group><article-title>Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin</article-title><source>Nature</source><volume>407</volume><fpage>1029</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1038/35039551</pub-id><year>2000</year><pub-id pub-id-type="pmid">11069186</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmer</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex</article-title><source>J Mol Biol</source><volume>339</volume><fpage>821</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.04.031</pub-id><year>2004</year><pub-id pub-id-type="pmid">15165853</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>BetaKlotho is required for metabolic activity of fibroblast growth factor 21</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>7432</fpage><lpage>7437</lpage><pub-id pub-id-type="doi">10.1073/pnas.0701600104</pub-id><year>2007</year><pub-id pub-id-type="pmid">17452648</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21</article-title><source>J Biol Chem</source><volume>282</volume><fpage>26687</fpage><lpage>26695</lpage><pub-id pub-id-type="doi">10.1074/jbc.M704165200</pub-id><year>2007</year><pub-id pub-id-type="pmid">17623664</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis</article-title><source>Genes Dev</source><volume>17</volume><fpage>1581</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1101/gad.1083503</pub-id><year>2003</year><pub-id pub-id-type="pmid">12815072</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potthoff</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response</article-title><source>Proc Natl Acad Sci U S A</source><volume>106</volume><fpage>10853</fpage><lpage>10858</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904187106</pub-id><year>2009</year><pub-id pub-id-type="pmid">19541642</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitteloud</surname><given-names>N</given-names></name><etal/></person-group><article-title>Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism</article-title><source>J Clin Invest</source><volume>117</volume><fpage>457</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1172/JCI29884</pub-id><year>2007</year><pub-id pub-id-type="pmid">17235395</pub-id></element-citation></ref><ref id="R38"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CD</given-names></name><name><surname>Podvin</surname><given-names>S</given-names></name><name><surname>Gillespie</surname><given-names>E</given-names></name><name><surname>Leeman</surname><given-names>SE</given-names></name><name><surname>Abraham</surname><given-names>CR</given-names></name></person-group><article-title>Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>19796</fpage><lpage>19801</lpage><pub-id pub-id-type="doi">10.1073/pnas.0709805104</pub-id><year>2007</year><pub-id pub-id-type="pmid">18056631</pub-id></element-citation></ref><ref id="R39"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrissat</surname><given-names>B</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name></person-group><article-title>Structural and sequence-based classification of glycoside hydrolases</article-title><source>Curr Opin Struct Biol</source><volume>7</volume><fpage>637</fpage><lpage>644</lpage><year>1997</year><pub-id pub-id-type="pmid">9345621</pub-id></element-citation></ref><ref id="R40"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization</article-title><source>Structure</source><volume>25</volume><fpage>1325</fpage><lpage>1336</lpage><fpage>e1323</fpage><pub-id pub-id-type="doi">10.1016/j.str.2017.06.016</pub-id><year>2017</year><pub-id pub-id-type="pmid">28757146</pub-id></element-citation></ref><ref id="R41"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belov</surname><given-names>AA</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology</article-title><source>Cold Spring Harb Perspect Biol</source><volume>5</volume><pub-id pub-id-type="doi">10.1101/cshperspect.a015958</pub-id><year>2013</year></element-citation></ref><ref id="R42"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase</article-title><source>J Biol Chem</source><volume>282</volume><fpage>30889</fpage><lpage>30900</lpage><pub-id pub-id-type="doi">10.1074/jbc.M700832200</pub-id><year>2007</year><pub-id pub-id-type="pmid">17595169</pub-id></element-citation></ref><ref id="R43"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>L</given-names></name><name><surname>Burke</surname><given-names>DF</given-names></name><name><surname>von Delft</surname><given-names>F</given-names></name><name><surname>Mulloy</surname><given-names>B</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name></person-group><article-title>Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin</article-title><source>Nature</source><volume>407</volume><fpage>1029</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1038/35039551</pub-id><year>2000</year><pub-id pub-id-type="pmid">11069186</pub-id></element-citation></ref><ref id="R44"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmer</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex</article-title><source>J Mol Biol</source><volume>339</volume><fpage>821</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.04.031</pub-id><year>2004</year><pub-id pub-id-type="pmid">15165853</pub-id></element-citation></ref><ref id="R45"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>CJ</given-names></name><name><surname>Harmer</surname><given-names>NJ</given-names></name><name><surname>Goodger</surname><given-names>SJ</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Gallagher</surname><given-names>JT</given-names></name></person-group><article-title>Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes</article-title><source>J Biol Chem</source><volume>280</volume><fpage>42274</fpage><lpage>42282</lpage><pub-id pub-id-type="doi">10.1074/jbc.M505720200</pub-id><year>2005</year><pub-id pub-id-type="pmid">16219767</pub-id></element-citation></ref><ref id="R46"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodger</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms</article-title><source>J Biol Chem</source><volume>283</volume><fpage>13001</fpage><lpage>13008</lpage><pub-id pub-id-type="doi">10.1074/jbc.M704531200</pub-id><year>2008</year><pub-id pub-id-type="pmid">18281281</pub-id></element-citation></ref><ref id="R47"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlessinger</surname><given-names>J</given-names></name><etal/></person-group><article-title>Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization</article-title><source>Mol Cell</source><volume>6</volume><fpage>743</fpage><lpage>750</lpage><year>2000</year><pub-id pub-id-type="pmid">11030354</pub-id></element-citation></ref><ref id="R48"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urakawa</surname><given-names>I</given-names></name><etal/></person-group><article-title>Klotho converts canonical FGF receptor into a specific receptor for FGF23</article-title><source>Nature</source><volume>444</volume><fpage>770</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1038/nature05315</pub-id><year>2006</year><pub-id pub-id-type="pmid">17086194</pub-id></element-citation></ref><ref id="R49"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Regulation of fibroblast growth factor-23 signaling by klotho</article-title><source>J Biol Chem</source><volume>281</volume><fpage>6120</fpage><lpage>6123</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500457200</pub-id><year>2006</year><pub-id pub-id-type="pmid">16436388</pub-id></element-citation></ref><ref id="R50"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunshee</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21</article-title><source>J Biol Chem</source><volume>291</volume><fpage>5986</fpage><lpage>5996</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.710582</pub-id><year>2016</year><pub-id pub-id-type="pmid">26797127</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p id="P35">Overall topology of the FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex. (<bold>a</bold>) Cartoon (left) and surface representation (right) of the ternary complex structure. &#x003b1;Klotho KL1 (cyan) and KL2 (blue) domains are joined by a short proline-rich linker (yellow; not visible in the surface presentation). FGF23 is in orange with its proteolytic cleavage motif in gray. FGFR1c is in green. NT, N-terminus; CT, C-terminus. (<bold>b</bold>) Binding interfaces between &#x003b1;Klotho<sup>ecto</sup> and the FGF23-FGFR1c<sup>ecto</sup> complex. The ternary complex (center) is shown in two different orientations related by a 180&#x000b0; rotation along the vertical axis. FGF23-&#x003b1;Klotho<sup>ecto</sup> (red) and FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> (pink) interfaces are visualized by pulling &#x003b1;Klotho<sup>ecto</sup> and FGF23-FGFR1c<sup>ecto</sup> complex away from each other. The separated components are shown to the left and right of the ternary complex.</p></caption><graphic xlink:href="nihms927628f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p id="P36">&#x003b1;Klotho is a non-enzymatic molecular scaffold. (<bold>a</bold>) Triosephosphate isomerase (TIM) barrel topology of &#x003b1;Klotho KL1 and KL2 domains. KL1 is in the same orientation as in <xref ref-type="fig" rid="F1">Fig. 1a</xref>, whereas KL2 has been superimposed onto KL1 and has thus been reoriented. The eight alternating &#x003b2; strands (red) and &#x003b1; helices (cyan/blue) which define the TIM barrel are labeled according to the standard nomenclature for the TIM fold<sup><xref rid="R8" ref-type="bibr">8</xref></sup>. KL1 and KL2 differ dramatically in the conformation of the &#x003b2;1&#x003b1;1 loop (wheat). In KL2, this loop protrudes away from the TIM barrel and serves as a Receptor Binding Arm (RBA; <xref ref-type="fig" rid="F1">Fig. 1</xref>). (<bold>b</bold>) Molecular surfaces of KLrP-glucosylceramide (Glc) (center; KLrP in yellow), KL1-Glc (left; KL1 in cyan) and KL2-Glc (right; KL2 in blue). Binding of Glc to KL1 and KL2 was simulated by superimposing KL1 and KL2 onto KLrP-Glc. In all cases, Glc is shown as pale gray sticks/surface. The divergent conformation of the &#x003b2;6&#x003b1;6 loop (pink) in KL1 almost seals off the entrance to the catalytic pocket, while the divergent conformations of &#x003b2;1&#x003b1;1 (RBA; wheat), &#x003b2;6&#x003b1;6 (pink) and &#x003b2;8&#x003b1;8 (green) loops in KL2 leave the central barrel cavity in KL2 in a more solvent-exposed state that is less capable of ligating substrate (see also <xref ref-type="fig" rid="F10">Extended Data Fig. 5</xref>). (<bold>c</bold>) Glycosidase activity of &#x003b1;Klotho<sup>ecto</sup>, sialidase, and &#x003b2;-glucuronidase. Bars: mean values; error bars: SD; dots: individual data points; n=3 independent experiments. RU, relative units.</p></caption><graphic xlink:href="nihms927628f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p id="P37">&#x003b1;Klotho simultaneously tethers FGFR1c by its D3 domain and FGF23 by its C-terminal tail. (<bold>a</bold>) Ternary complex structure in surface representation. Coloring is the same as in <xref ref-type="fig" rid="F1">Fig. 1a</xref>, except that the alternatively spliced region of FGFR1c is highlighted in purple. Red box: perimeter of interface between distal tip of &#x003b1;Klotho <underline>R</underline>eceptor <underline>B</underline>inding <underline>A</underline>rm (RBA) and the hydrophobic FGFR1c D3 groove. Blue box: perimeter of &#x003b1;Klotho&#x02212;FGF23<sup>C-tail</sup> interface. (<bold>b</bold>) RBA stretches out of the KL2 domain of &#x003b1;Klotho<sup>ecto</sup> and latches onto the FGFR1c D3 domain. Upper panel: interface between the distal tip of RBA and the D3 groove detailing hydrophobic interactions (gray transparent surfaces). Note that Leu342 (red) from the spliced region of the D3 groove is strictly conserved in &#x0201c;c&#x0201d; splice isoforms of FGFR1-3 and FGFR4 and is mutated in Kallmann syndrome<sup><xref rid="R37" ref-type="bibr">37</xref></sup>. Lower panel: Close-up view of the extended &#x003b2; sheet between the RBA-&#x003b2;1:RBA-&#x003b2;2 strand pair and the four-stranded &#x003b2; sheet in D3 (&#x003b2;C&#x02019;-&#x003b2;C-&#x003b2;F-&#x003b2;G). This structure forms via hydrogen bonding (dashed yellow lines) between backbone atoms of RBA-&#x003b2;1 and D3-&#x003b2;C&#x02019;. (<bold>c</bold>) Both KL domains of &#x003b1;Klotho<sup>ecto</sup> participate in tethering of the flexible C-terminal tail of FGF23 (FGF23<sup>C-tail</sup>). FGF23<sup>C-tail</sup> residues Asp-188 &#x02013; Thr-200 thread through the KL1-KL2 cleft and the &#x003b2;-barrel cavity of KL2. Of these residues, Asp188 &#x02013; Leu-193 adopt a cage-like conformation that is partially stabilized by intramolecular hydrogen bonds (dashed green lines). Dashed yellow lines: intermolecular hydrogen bonds; gray transparent surfaces: hydrophobic interactions. Note that Tyr-433 from the KL1 &#x003b1;7 helix deep inside the KL1-KL2 cleft plays a prominent role in tethering the cage-like structure in the FGF23<sup>C-tail</sup> formed by Asp-188 &#x02013; Leu-193. Dashed circle (shown at greater magnification below): the KL1&#x02212;KL2 interface where residues from both &#x003b1;Klotho domains jointly coordinate a Zn<sup>2+</sup> ion (orange sphere).</p></caption><graphic xlink:href="nihms927628f3"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><p id="P38">Mutagenesis experiments validate the crystallographically-deduced mode of ternary complex formation. (<bold>a</bold>) SEC-MALS analysis of FGFR1c<sup>ecto</sup> interaction with wild-type &#x003b1;Klotho<sup>ecto</sup> or its RBA deletion mutant. RU, relative units. (<bold>b&#x02013;e</bold>) Representative immunoblots of phosphorylated ERK (upper panels) and total ERK (lower panels, done as sample loading controls) in total HEK293 cell lysates (n=3 independent experiments for each panel). (<bold>b</bold>) Analysis of the effects of RBA deletion on the co-receptor activity of &#x003b1;Klotho<sup>ecto</sup> and &#x003b1;Klotho&#x02122; isoforms. (<bold>c</bold>) Analysis of mutations in the &#x003b1;Klotho binding pocket that engages the FGF23<sup>C-tail</sup>. (<bold>d</bold>) Analysis of mutations in the FGF23<sup>C-tail</sup> that disrupt &#x003b1;Klotho&#x02212;FGF23<sup>C-tail</sup> interaction. (<bold>e</bold>) Analysis of mutations of the four Zn<sup>2+</sup>-coordinating amino acids in &#x003b1;Klotho.</p></caption><graphic xlink:href="nihms927628f4"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><p id="P39">HS dimerizes two 1:1:1 FGF23-FGFR1c-&#x003b1;Klotho complexes into a symmetric 2:2:2:2 FGF23-FGFR1c-&#x003b1;Klotho-HS signal transduction unit. (<bold>a</bold>) SEC-MALS analysis of FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complex in the absence or presence of heparin hexasaccharide (HS6) present at various molar ratios. (<bold>b</bold>) SEC-MALS analysis of FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complexes containing HS-binding site mutations of FGF23 and FGFR1c. (<bold>c&#x02013;e</bold>) Representative immunoblots of phosphorylated ERK (top panels) and total ERK (bottom panels; sample loading controls) in total BaF3 cell lysates (n=3 independent experiments for each panel). (<bold>c</bold>) Analysis of HS dependency of FGF23 signaling. (<bold>d, e</bold>) Analysis of mutations in the HS-binding site of FGFR1c (<bold>d</bold>) and in the HS-binding site or secondary receptor-binding site of FGF23 (<bold>e</bold>). (<bold>f</bold>) SEC-MALS analysis of FGF23-FGFR1c<sup>ecto</sup>-&#x003b1;Klotho<sup>ecto</sup> complexes containing a secondary receptor-binding site mutation in FGF23, a secondary ligand-binding site mutation in FGFR1c, or a direct receptor-receptor binding site mutation in FGFR1c. In (<bold>b</bold>) and (<bold>f</bold>), wild-type ternary complex served as controls. (<bold>g</bold>) Molecular surface of a 2:2:2:2 FGF23-FGFR1c-&#x003b1;Klotho-HS dimer in two orientations related by a 90&#x000b0; rotation around the horizontal axis: a side-view looking parallel to the plane of a cell membrane (left) and a bird&#x02019;s-eye view looking down onto the plane of a cell membrane (right). HS molecules are shown as black sticks.</p></caption><graphic xlink:href="nihms927628f5"/></fig></floats-group></article>
